CCRN250516C30000
- 0.00
- 0.000.00%
Cross Country Healthcare Newsroom
Catalyst Watch: Apple, Amazon & Microsoft's Earnings Confessions, Meta's LlamaCon and the Jobs Report
Cross Country Healthcare | 10-K/A: Annual report (Amendment)
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Barrington Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Cross Country Healthcare Is Maintained at Market Perform by Barrington Research
Cross Country Healthcare Price Target Maintained With a $18.61/Share by Barrington Research
Cross Country Healthcare Analyst Ratings
Hold Rating Maintained for Cross Country Healthcare Amidst Profitability Decline and Pending Aya Healthcare Merger
Cross Country Infrastructure Services and Tesmec USA Forge Strategic Partnership to Deliver Advanced Trenching Solutions in the US
Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Truist Financial Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Maintains Target Price $18.61
Analysts' Opinions Are Mixed on These Healthcare Stocks: Edgewise Therapeutics (EWTX) and Cross Country Healthcare (CCRN)
Top Premarket Decliners
UBS Maintains Cross Country Healthcare(CCRN.US) With Hold Rating, Raises Target Price to $18.61
Cross Country Healthcare Falls on Report About FTC Review of Aya Deal
Express News | Watching Shares Of Cross Country Healthcare; Traders Circulate Comments From M&A Blog
JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Express News | Cross Country Healthcare Inc : UBS Raises Target Price to $18.61 From $14
William Blair Keeps Their Hold Rating on Cross Country Healthcare (CCRN)
Cross Country Healthcare | 10-K: FY2024 Annual Report